Union City, CA, United States of America

Roy Leguidleguid

USPTO Granted Patents = 31 


 

Average Co-Inventor Count = 4.6

ph-index = 17

Forward Citations = 4,862(Granted Patents)


Company Filing History:


Years Active: 2000-2025

Loading Chart...
Loading Chart...
Loading Chart...
31 patents (USPTO):

Title: **Roy Leguidleguid: Innovator in Thrombectomy Technologies**

Introduction

Roy Leguidleguid, based in Union City, California, is a remarkable inventor with an impressive portfolio of 30 patents. His contributions to medical technology, particularly in thrombectomy apparatuses and methods, have significantly advanced the field of vascular surgery.

Latest Patents

Among his latest innovations, Leguidleguid has developed thrombectomy apparatuses designed to efficiently remove material, such as clots, from within the body. His work includes methods for inverting thrombectomy apparatuses that enhance the ability to reload and reuse components of the devices. Furthermore, he has created mechanical thrombectomy apparatuses that feature improved tracking capabilities, making them effective in navigating through tortuous vessels. These apparatuses are also designed to handle clots that exceed the size of the tractor portion, thereby expanding their applicability in clinical settings.

Career Highlights

Roy Leguidleguid has an extensive career within the medical device industry, having worked with notable companies such as Stryker Corporation and Baxano, Inc. His experience in these organizations has provided him with unique insights into the challenges faced in medical technology, fueling his innovative spirit.

Collaborations

Throughout his career, Leguidleguid has collaborated with distinguished professionals, including Michael P. Wallace and Jefferey C. Bleam. These partnerships have played a crucial role in enhancing the development of his patented technologies, ensuring that they meet the specific needs of medical practitioners and patients alike.

Conclusion

Roy Leguidleguid stands out as a leading inventor in the field of thrombectomy technologies. His innovations, combined with valuable collaborations and a solid career background, underscore his commitment to advancing medical device technology and improving patient outcomes. His contributions will undoubtedly continue to influence the future of vascular treatment methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…